Merck & Co Inc
(MEX:MRK)
MXN
2337.01
-53.99 (-2.26%)
Market Cap: 6.04 Til
Enterprise Value: 6.57 Til
PE Ratio: 143.87
PB Ratio: 8.12
GF Score: 75/100 - Q1 2024 Merck & Co Inc Earnings Call TranscriptApr 25, 2024MXN2227.52 (+2.53%)Earnings
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2024
- Merck & Co Inc at Leerink Partners Global Biopharma Conference TranscriptMar 11, 2024
- Merck & Co Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Merck & Co Inc Earnings Call TranscriptFeb 01, 2024MXN2140.19 (+2.86%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Merck & Co Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Merck & Co Inc at Evercore ISI HealthCONx Conference TranscriptNov 30, 2023
- Merck & Co Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Merck & Co Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Merck & Co Inc Earnings Call TranscriptOct 26, 2023MXN1900.71Earnings
- Merck & Co Inc To Host ESMO Call (Virtual) TranscriptOct 22, 2023
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Merck & Co Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Merck & Co Inc Earnings Call TranscriptAug 01, 2023MXN1788 (+0.12%)Earnings
- Merck & Co Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Merck & Co Inc Investor Event at ASCO 2023 TranscriptJun 05, 2023
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 23, 2023
- Merck & Co Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Merck & Co Inc Earnings Call TranscriptApr 27, 2023MXN2057.66Earnings
- Merck & Co Inc Acquisition of Prometheus Biosciences- M&A Call TranscriptApr 17, 2023
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Merck & Co Inc Investor Event at ACC.23/WCC TranscriptMar 07, 2023
- Q4 2022 Merck & Co Inc Earnings Call TranscriptFeb 02, 2023MXN1922.55 (-3.50%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Merck & Co Inc at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Merck & Co Inc Earnings Call TranscriptOct 27, 2022MXN1976.32 (+0.84%)Earnings
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Merck & Co Inc Earnings Call TranscriptJul 28, 2022MXN1848 (-0.65%)Earnings
- Merck & Co Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Merck & Co Inc at ASCO Annual Meeting TranscriptJun 07, 2022
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 24, 2022
- Merck & Co Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Merck & Co Inc Earnings Call TranscriptApr 28, 2022MXN1794.01 (+3.52%)Earnings
- Merck & Co Inc Cardiovascular Event TranscriptApr 05, 2022
- Merck & Co Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Merck & Co Inc ESG Investor Event TranscriptFeb 23, 2022
- Merck & Co Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Merck & Co Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Q4 2021 Merck & Co Inc Earnings Call TranscriptFeb 03, 2022MXN1632 (-3.41%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Merck & Co Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Merck & Co Inc Earnings Call TranscriptOct 28, 2021MXN1763.67 (+6.50%)Earnings
- Acceleron Pharma Inc Acquired by Merck & Co Inc Call TranscriptSep 30, 2021
- Merck & Co Inc Oncology Event at ESMO 2021 TranscriptSep 20, 2021
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Merck & Co Inc Earnings Call TranscriptJul 29, 2021MXN1527.01 (-2.37%)Earnings
- Merck & Co Inc at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 22, 2021
- Merck & Co Inc Oncology Event at ASCO TranscriptJun 07, 2021
- Merck & Co Inc at CECP CEO Investor Forum (Virtual) TranscriptJun 07, 2021
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Merck & Co Inc Investor Day (Virtual) TranscriptMay 03, 2021
- Q1 2021 Merck & Co Inc Earnings Call TranscriptApr 29, 2021MXN1404.95 (-3.88%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Merck & Co Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Merck & Co Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Merck & Co Inc Earnings Call TranscriptFeb 04, 2021MXN1485.09 (-0.79%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Q3 2020 Merck & Co Inc Earnings Call TranscriptOct 27, 2020MXN1572.29 (-0.49%)Earnings
- Merck & Co Inc Oncology Virtual IR Briefing -- ESMO 2020 TranscriptSep 22, 2020
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Seattle Genetics Inc Discussion of Oncology Collaborations with Merck & Co Inc - Conference Call TranscriptSep 14, 2020
- Merck & Co Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Merck & Co Inc Earnings Call TranscriptJul 31, 2020MXN1698.15 (+1.83%)Earnings
- Merck & Co Inc Oncology Event at ASCO 2020 TranscriptJun 02, 2020
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 26, 2020
- Merck & Co Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Merck & Co Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Merck & Co Inc Earnings Call TranscriptApr 28, 2020MXN1887.89 (-5.35%)Earnings
- Merck & Co Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Merck & Co Inc Earnings Call TranscriptFeb 05, 2020MXN1516.14 (-3.92%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Merck & Co Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Q3 2019 Merck & Co Inc Earnings Call TranscriptOct 29, 2019MXN1567.51 (+4.95%)Earnings
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Merck & Co Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Merck & Co Inc Earnings Call TranscriptJul 30, 2019MXN1513.65 (+2.39%)Earnings
- Merck & Co Inc Investor Day TranscriptJun 20, 2019
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 28, 2019
- Q1 2019 Merck & Co Inc Earnings Call TranscriptApr 30, 2019MXN1421.64 (+2.76%)Earnings
- Q4 2018 Merck & Co Inc Earnings Call TranscriptFeb 01, 2019MXN1407.33 (+4.81%)Earnings
Merck & Co Inc at Evercore ISI HealthCONx Conference Transcript
Nov 30, 2023 / 06:20PM GMT
Release Date Price:
MXN1770
(+1.09%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Listen, thank you guys for being here. Apologies, I'm a couple of minutes behind. Pleasure to have Merck management join us. This is our last fireside of this conference, at least from my end. So really looking forward to it. Peter promised it will be action-packed. And so let's jump right into it.
Questions & Answers
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
I think it will be a great idea, maybe let me turn it over to you, Peter and Eliav, to kick things off. Maybe frame for us what's on top in terms of priority list on your mind, and we'll jump right in.
Eliav Barr
Merck & Co., Inc. - Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories
Sure. This has been a tremendous year for Merck, and we're looking forward to 2024. The things that are top of mind for us,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)